Pain in chronic liver disease compared to other chronic conditions: Results from a contemporary nationally representative cohort study.

IF 5.6 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Hepatology Communications Pub Date : 2024-12-11 eCollection Date: 2025-01-01 DOI:10.1097/HC9.0000000000000605
Grace Y Zhang, Aly Cortella, Jennifer C Lai, Jessica B Rubin
{"title":"Pain in chronic liver disease compared to other chronic conditions: Results from a contemporary nationally representative cohort study.","authors":"Grace Y Zhang, Aly Cortella, Jennifer C Lai, Jessica B Rubin","doi":"10.1097/HC9.0000000000000605","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pain is common in patients with chronic liver disease. Our limited understanding of patterns and severity of pain in this population hinders the development of effective cirrhosis-specific pain management strategies.</p><p><strong>Methods: </strong>Using cross-sectional data from the 2016-2021 National Health Interview Survey, we examined rates, severity, and functional limitations due to pain in respondents with liver disease (viral hepatitis, cirrhosis, and liver cancer), compared to the general population and those with other chronic conditions associated with pain (ie, arthritis, diabetes, and chronic kidney disease). Categorical and continuous variables were compared using χ2 and t test. Multivariable logistic regression was used to determine the predictors associated with pain and opioid use.</p><p><strong>Results: </strong>Our liver disease cohort comprised 5267 participants (63% viral hepatitis, 49% cirrhosis, and 2% liver cancer). Participants with liver disease were more likely to report pain than those without liver disease (42% vs. 22%); they were also more likely to report severe pain (42% vs. 30%) and functional limitations by pain (28% vs. 13%) (p < 0.001 for all). On multivariable logistic regression, liver disease is an independent predictor of pain (OR: 2.31, 95% CI: 2.05-2.59, p < 0.001), even after adjustment for demographic factors. Liver disease respondents had similar rates of pain as those with diabetes (p = 0.8) and were more functionally limited by pain than those with arthritis (p < 0.001). Adjusted for demographic and pain-related factors, liver disease was also an independent predictor of chronic opioid use (OR: 1.47, 95% CI: 1.12-1.92, p = 0.0054).</p><p><strong>Conclusions: </strong>Liver disease independently increases the likelihood of experiencing widespread and debilitating pain. Clinicians should consider liver disease a painful condition, ensuring that they are frequently assessing and appropriately treating pain in all liver disease patients.</p>","PeriodicalId":12978,"journal":{"name":"Hepatology Communications","volume":"9 1","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637743/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology Communications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HC9.0000000000000605","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pain is common in patients with chronic liver disease. Our limited understanding of patterns and severity of pain in this population hinders the development of effective cirrhosis-specific pain management strategies.

Methods: Using cross-sectional data from the 2016-2021 National Health Interview Survey, we examined rates, severity, and functional limitations due to pain in respondents with liver disease (viral hepatitis, cirrhosis, and liver cancer), compared to the general population and those with other chronic conditions associated with pain (ie, arthritis, diabetes, and chronic kidney disease). Categorical and continuous variables were compared using χ2 and t test. Multivariable logistic regression was used to determine the predictors associated with pain and opioid use.

Results: Our liver disease cohort comprised 5267 participants (63% viral hepatitis, 49% cirrhosis, and 2% liver cancer). Participants with liver disease were more likely to report pain than those without liver disease (42% vs. 22%); they were also more likely to report severe pain (42% vs. 30%) and functional limitations by pain (28% vs. 13%) (p < 0.001 for all). On multivariable logistic regression, liver disease is an independent predictor of pain (OR: 2.31, 95% CI: 2.05-2.59, p < 0.001), even after adjustment for demographic factors. Liver disease respondents had similar rates of pain as those with diabetes (p = 0.8) and were more functionally limited by pain than those with arthritis (p < 0.001). Adjusted for demographic and pain-related factors, liver disease was also an independent predictor of chronic opioid use (OR: 1.47, 95% CI: 1.12-1.92, p = 0.0054).

Conclusions: Liver disease independently increases the likelihood of experiencing widespread and debilitating pain. Clinicians should consider liver disease a painful condition, ensuring that they are frequently assessing and appropriately treating pain in all liver disease patients.

与其他慢性疾病相比,慢性肝病患者的疼痛:一项具有全国代表性的当代队列研究的结果。
背景:疼痛在慢性肝病患者中很常见。我们对这一人群的疼痛模式和严重程度了解有限,这阻碍了针对肝硬化的有效疼痛管理策略的制定:利用 2016-2021 年全国健康访谈调查的横断面数据,我们研究了肝病(病毒性肝炎、肝硬化和肝癌)受访者与普通人群和患有其他与疼痛相关的慢性疾病(即关节炎、糖尿病和慢性肾病)的受访者相比,因疼痛而导致的比例、严重程度和功能限制。分类变量和连续变量的比较采用χ2和t检验。多变量逻辑回归用于确定与疼痛和阿片类药物使用相关的预测因素:我们的肝病队列包括 5267 名参与者(63% 为病毒性肝炎,49% 为肝硬化,2% 为肝癌)。与无肝病的参与者相比,有肝病的参与者更有可能报告疼痛(42% 对 22%);他们也更有可能报告剧烈疼痛(42% 对 30%)和因疼痛而功能受限(28% 对 13%)(所有数据的 p 均小于 0.001)。在多变量逻辑回归中,肝病是疼痛的独立预测因素(OR:2.31,95% CI:2.05-2.59,p <0.001),即使在调整了人口统计学因素后也是如此。肝病受访者的疼痛发生率与糖尿病受访者相似(p = 0.8),与关节炎受访者相比,肝病受访者因疼痛而受到的功能限制更大(p < 0.001)。经人口统计学和疼痛相关因素调整后,肝病也是长期使用阿片类药物的独立预测因素(OR:1.47,95% CI:1.12-1.92,p = 0.0054):结论:肝脏疾病会单独增加患者经历广泛和衰弱性疼痛的可能性。临床医生应将肝病视为一种疼痛性疾病,确保经常对所有肝病患者的疼痛进行评估和适当治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hepatology Communications
Hepatology Communications GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
8.00
自引率
2.00%
发文量
248
审稿时长
8 weeks
期刊介绍: Hepatology Communications is a peer-reviewed, online-only, open access journal for fast dissemination of high quality basic, translational, and clinical research in hepatology. Hepatology Communications maintains high standard and rigorous peer review. Because of its open access nature, authors retain the copyright to their works, all articles are immediately available and free to read and share, and it is fully compliant with funder and institutional mandates. The journal is committed to fast publication and author satisfaction. ​
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信